Evidence map›Paper›PMID 39057160›Full record

Observational studyCurrent oncology (Toronto, Ont.)2024

Critical Issues for Patients and Caregivers in Neuro-Oncology during the COVID-19 Pandemic: What We Have Learnt from an Observational Study.

Elena Anghileri, Irene Tramacere, Sara Morlino, Catia Leuzzi, Lorena Pareja Gutierrez, Saba Motta, Antonio Silvani, Anna Amato, Francesca Romana Berrini

Abstract readObservational Study
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elena AnghileriNeuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.ORCID 0000-0001-7383-3108
Irene TramacereDepartment of Research and Clinical Development, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Sara MorlinoRadiotherapy Unit, Neurosurgery Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Catia LeuzziClinical Neuro-Science Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Lorena Pareja GutierrezClinical Neuro-Science Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Saba MottaScientific and Patients Library, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.ORCID 0000-0003-4769-8074
Antonio SilvaniNeuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.
Anna AmatoDepartment of Medicine and Surgery, University of Milano-Bicocca, 20126 Milan, Italy.ORCID 0009-0004-2424-7494
Francesca Romana BerriniAITC-Associazione Italiana Tumori Cerebrali (Italian Brain Tumor Association), 20133 Milan, Italy.

Funding

Governo Italiano RRC-2023-23683418
6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic affected neuro-oncological patients and their caregivers regarding tumor care and emotional functioning, including Quality of Life (QoL). This study aimed to understand how COVID-19 affected their psychological state and the relations between patients and health personnel in neuro-oncology.

methodsA cross-sectional study was conducted on neuro-oncological patients and their caregivers.

resultsA total of 162 patients and 66 caregivers completed the questionnaire. Altogether, 37.5% of patients perceived a greater risk of contracting COVID-19 compared to the general population. On a 0-10 scale, the patients' tumor-related anxiety score was 5.8, and their COVID-19-related score was 4.6. The caregivers reported 7.7 and 5.5, respectively. QoL was described as at least good in 75% of both patients and caregivers; the caregivers' care burden increased in 22.7% of cases during the pandemic, with no correlation with QoL. Future perception often changed, both in patients and caregivers. In 18% of cases, the cancer treatment schedule was changed, either by patient decision or by medical decision. However, 93.5% of patients were satisfied with their overall care.

conclusionsA considerable proportion of patients and caregivers still perceived the tumor disease as more burdensome than the pandemic, and their future as more uncertain. Such data suggest the need to build a productive alliance between patients and health professionals.

Indexed as

CaregiversCOVID-19Quality of LifeAdultAgedAnxietyBrain NeoplasmsCross-Sectional StudiesFemaleHumansMaleMiddle AgedSARS-CoV-2Surveys and Questionnairesanxiety(brain) neoplasmscaregiver burdencaregiverscommunicationCOVID-19pandemicsperceptionpsycho-oncologyquality of life

Identifiers

PMID39057160
PMCPMC11275436

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.